Abstract:
Introduction

37
The small intestine plays a key role in the regulation of energy balance and fat homeostasis anxiety, suggesting that it has a specific inhibitory effect on eating (44, 46, 48). The exact 46 mechanism by which OEA inhibits eating is still poorly understood, but the effect seems to 47 depend on the feeding state of the animals: in ad libitum-fed rats, OEA delays the onset of eating 48 and decreases meal frequency without altering meal size, indicating that its hypophagic effect is 49 mainly due to a prolongation of satiety, i.e., the state of non-eating between meals. In food-50 deprived rats, however, OEA also reduces meal size (20, 24) , suggesting that it can also affect 51 satiation (= meal termination). 58 effect (37, 46). Finally, as it has been reported that OEA's satiety effect was abolished in rats 82 after treatment with the neurotoxin capsaicin or after a total subdiaphragmatic vagotomy (20, 48, 83 63), we examined the role of abdominal vagal afferents in OEA's satiety effect by IP injecting 84 OEA in rats after subdiaphragmatic vagal deafferentation (SDA) or sham surgery. SDA is a 85 surgical procedure that eliminates all abdominal vagal afferents, but leaves about 50% of the 86 vagal efferents intact; it is considered to be the most complete and selective abdominal vagal climate-controlled room (22 ± 2 °C and 60% relative humidity). Animals were fed ad libitum 94 standard chow (N3433, 12.6% of energy from fat, caloric density: 3.1 Kcal/g, ProvimiKliba SA,
95
Switzerland) or high-fat diet (HFD, 60% of energy from fat, caloric density: 5.2 Kcal/g, No.
96 E15742, SSNIFF GmbH, Germany) unless otherwise stated. The animals were adapted to 97 housing and diet conditions for at least 10 days prior to catheter implantation (see below). All Catheter assembly 101 Catheters with custom-made headsets were manufactured as described before (59, 62). 
IP catheter implantation
123
All animals were equipped with IP catheters for substance administrations. The IP 124 catheters were implanted under isoflurane anesthesia as described previously (30 Switzerland) and 4 mg/kg Borgal 24% were injected for 2 days after surgery for analgesia and 131 infection prophylaxis, respectively. To keep the catheters patent they were flushed every 2-3 132 days with 0.5 ml 0.9% sterile saline. All rats were allowed to recover from surgery for at least 2 133 weeks before the experiments started. (Fig. 1) . The food cups were opened shortly before dark onset, and the program for cumulative food intake and meal pattern recordings was started. Vehicle and OEA were 149 administered in a within-subject cross-over design with two intervening days between trials.
150
Continuous food intake recordings after the first trial showed that two intervening days were 151 sufficient to avoid carry-over effects. 
155
Rats were equipped with VC and HPV catheters for blood samplings in addition to the IP 156 catheter. The VC and HPV catheter headsets were led SC from 2 cm midline interscapular 157 incisions to puncture wounds 1 cm rostral to the incision and the metal ends were exteriorized.
158
The distal ends of the catheters were led subcutaneously to a 4 cm incision in the midline of the 159 abdomen. The HPV catheter was inserted into the ileocolic vein, advanced into the HPV so that 160 it ended 1 to 2 cm distal from the liver, then fixed to the ileocolic vein with sutures and 161 histoacryl glue (Braun, Tuttlingen, Germany), and anchored to the inside of the abdominal wall 162 with silk suture (Silkam, 3/0; Braun, Tuttlingen, Germany). For the VC catheter implantation, the 163 inferior VC was exposed and its surface just rostral to the renal veins was grasped with forceps 164 and lifted a few millimeters. The caudal aspect of the resulting tent-shape was pierced with a 21- which was fed the same diet as the experimental rats, was anesthetized with isoflurane, and 190 about9 ml blood was taken by heart puncture. About 1.5 ml blood was given to each 191 experimental rat. This procedure did not affect several metabolites and plasma cortisol in our 192 previous experiments (3). The experiment followed a within-subject cross-over design in which 
198
The circulating plasma levels of PYY and active GLP-1 were determined using an 30 min prior to dark onset as described above, in a within-subject cross-over design with two 242 intervening days between trials. Cumulative food intake was recorded for 24 h after 243 administration and meal patterns were analyzed as described (Fig. 1) .
244
At the end of the experiment, SDA was verified functionally by the loss of cholecystokinin The meal pattern analysis revealed that OEA's eating-inhibitory effect in both diet groups concentrations from baseline to a peak at 30 min in both diet groups. This was followed by a 302 sharp decline to below baseline levels at 120 min. Similarly, HPV and VC plasma NEFA levels 303 increased (all Ps < 0.05) from baseline to 30 min and decreased to below baseline levels within 304 120 min after OEA injection in both diet groups (Fig. 3B) .The baseline plasma NEFA and BHB 305 levels did not differ between diet groups (P > 0.05).
306
IP OEA injection decreased HPV plasma PYY concentration (Mixed ANOVA, P < 0.05, Furthermore, IP OEA injection substantially increased plasma BHB concentration in trunk blood 325 samples collected from ad libitum HFD-but not chow-fed rats (P < 0.005, Table 1 ). OEA did not 326 significantly affect plasma NEFA levels in both diet groups (P > 0.05). Fig. 6A and B) . In ad libitum-fed SDA and sham rats OEA reduced food intake primarily 332 during the first hour (Ps < 0.05); thereafter the cumulative food intake difference between OEA 333 and vehicle treated rats was still present to some degree between 3 and 6 hours, but had In ad libitum-fed rats, the eating-inhibitory effect of OEA was more pronounced with the 373 HFD than with chow. This is remarkable because prolonged consumption of HFD decreases the 374 eating-inhibitory effect of several gut peptides (54, 66). Interestingly, we recently found that 
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This raises the possibility that the eating-inhibitory effect of OEA might be due to visceral pain.
405
Using the lower OEA dose (10 mg/kg BW), however, OEA reduced rather than enhanced 406 nociceptive responses (61) and, when administered to mice with a genetic deletion of TRPV1,
407
OEA still inhibited eating (38). These observations suggest that an induction of visceral pain is 408 probably not crucial for the eating-inhibitory effect of OEA reported here. The changes in the circulating BHB levels and enzyme protein expression following OEA 
448
It should also be noted that BHB levels in the HPV and VC were measured in animals that 449 had access to a test meal after 13 h food deprivation. In contrast, the analysis of mHMG-CoAS2 450 expression was performed in rats fed ad libitum and sacrificed for tissue collection and BHB 451 measurements from trunk blood 30 min after OEA administration. In this situation OEA 452 increased the plasma BHB levels only in HFD-fed animals, but had no effect in chow-fed rats.
453
Therefore, the failure of OEA to affect BHB levels in chow-fed rats without prior test meal may 454 be related to the absence of an increase in mHMG-CoAS2 expression observed in the jejunum 455 under the same feeding condition. Thus, OEA seems to limit food intake in chow-fed rats 456 independent of an overt stimulation of intestinal FAO and ketogenesis. Therefore, the exact 457 peripheral mechanisms underlying the inhibition of eating by OEA under different conditions 458 still remain to be identified.
459
We measured plasma levels of PYY and GLP-1 to examine whether these peptides might 460 contribute to the inhibition of eating by OEA. The higher postprandial PYY and GLP-1 levels in 461 both diet groups were expected because these peptides are released in response to a meal (13) . and also following intraluminal OEA administration in anesthetized rats (12, 37). In another 472 study (46), OEA had no effect on gut peptide levels in trunk blood plasma from freely-feeding 473 rats at different time points following OEA administration. The discrepant findings are likely 474 due to methodological differences between these studies. We collected blood at various time Probably the most important finding of our study in the light of previous reports is that 487 OEA did not require intact abdominal vagal afferents to reduce food intake. This is the first showed that higher doses of OEA may cause nonspecific side effects (46), we performed our 541 experiments with 10 mg/kg, a dose that still reliably inhibits eating (24, 48) . IP administration of 542 this dose (10 mg/kg) increased the OEA plasma level to 0.13 µg/ml (325.5 pmol/ml) in rats (6).
543
In contrast, the plasma OEA level in response to a meal was only 5.9 pmol/ml (18) . Therefore, it In general, the effect of OEA on food intake observed in this experiment mirrored the 552 effects reported before (20, 24) , i.e., it was more pronounced after food deprivation than in ad Ad libitum-fed rats (n = 6/diet) received OEA (10 mg/2 ml/kg) or vehicle (2 ml/kg) 30 min prior 823 to dark onset. Food cups were closed and trunk blood samples were taken 30 min after injection.
824
Data are expressed as means ± SEM. 
